Loading...
RAS and ROS in Rhabdomyosarcoma
The 5-year survival for localized rhabdomyosarcoma is over 70%, but only 30% for patients presenting with metastatic disease. In this issue of Cancer Cell, Dyer and colleagues performed whole-genome and RNA sequencing on human rhabdomyosarcoma and identified RAS mutations and oxidative stress as pot...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3985483/ https://ncbi.nlm.nih.gov/pubmed/24332036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2013.11.015 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|